Recent Risperdal Lawsuit Or Settlement Case: $70M Awarded

July 18, 2016 – – A recent lawsuit has ended with a $70 million loss for Janssen Pharmaceuticals. The pharmaceutical company is the producer of Risperdal, a drug that has been approved since 1993 to treat schizophrenia in adults.

It was reported that the said amount “has been awarded against Janssen Pharmaceuticals ending a Risperdal lawsuit brought by plaintiff Andrew Yount.” The plaintiff alleged that he experienced excessive breast growth while he was taking the antipsychotic drug. Yount, who was born in 1998, began taking the drug in 2003 to treat a severe psychiatric issue, and states that one year later in 2004, he began experiencing growth in his breast area.

“It’s not an uncommon complaint,” says a spokesperson for the organization with website at www.risperdal-settlement.com, which focuses on this drug and its complications and lawsuits.

This particular trial focused on the pharmaceutical company, which is a subsidiary of Johnson & Johnson, and stated that the company withheld vital information that shows a substantial link between Risperdal and excessive breast growth. Attorneys used as evidence labels from the drug as well as internal documents from the pharmaceutical company and argued that purposeful steps were taken to shield the community from this information. They pointed out that Janssen failed to acknowledge and reveal all of the risks associated with the drug.

As a result, the jury found that the pharmaceutical company intentionally falsified or destroyed records that would alert the community of this risk and awarded $70 million in compensatory damages to the plaintiff. This is the fifth case against Janssen to go to trial, and the largest award amount to date.

Risperdal is an atypical antipsychotic drug that changes how certain natural substances in the brain react. The FDA initially approved the drug in the 1990’s for use in adults, and as of September 2012, there have been more than 400 lawsuits against the drug for various side effects. Side effects include male breast growth as well as high blood sugar, stroke, heart attack, tardive dyskinesia, and in some cases, death.

Those interested in keeping up with the claims and settlements against the pharmaceutical company involving Risperdal can follow the Twitter account at https://twitter.com/Risperdallawsui.

###

Contact Drug-Lawsuits.org:

info@drug-lawsuits.org

ReleaseID: 60011378

SecondaryID: 7ccb14ad50ee999e